The Medical Alley Venture Report is a quarterly analysis of investment, M&A and other factors driving growth in Medical Alley®, the epicenter of health innovation and care®.
Medical Alley Starts: Venture platform to lower the cost of starting, scaling, and pivoting new ventures.
Medical Alley Global: Bringing Medical Alley to the world and the world to Medical Alley.
The Q1 2023 report includes information on:
- Medical Alley Starts & Global highlights
- Private and public markets activity
- SBIR/STTR funding
- Job growth in Medical Alley
In Q1 2023, Medical Alley startups raised more than $400 million – $277 million in private capital, $120
million through secondary offerings, and almost $7 million in SBIR/STTR. While the overall numbers are somewhat distorted by a single large private raise, the Medical Alley ecosystem showed resilience in an uncertain market. The increase in SBIR/STTR funding continues to be encouraging.
Digital health and medical device companies were the main drivers in private funding. Biopharma companies recorded a decrease after a record-breaking 2022.
Medical Alley tracked less than half the number of M&A transactions than in any of last year’s quarters, in line with expectations given the broader market slow down. Read the full report by clicking the button below.
